A 61-Year-Old Man With Small Cell Lung Cancer

Ticiana Leal, MD, presents a case of a 61-year-old man with small cell lung cancer.

EP. 1: Presentation of a Patient with Small Cell Lung Cancer

December 18th 2020

Dr Ticiana Leal, MD, outlines the specific demographic and diagnosis of a patient with small cell lung cancer.

EP. 2: Assessing Treatment Options for the Case-Based Patient

December 18th 2020

Dr Ticiana Leal, MD, comments on the treatment given, the effectiveness of treatment, and the future prognosis of this patient with small cell lung cancer.

EP. 3: Defining Platinum Sensitivity vs Resistance after First-Line Treatment in Small Cell Lung Cancer

December 18th 2020

Dr Ticiana Leal, MD, lists the treatment options associated with first-line therapy and its relation to platinum sensitivity.

EP. 4: Analyzing the Role of Topotecan and Lurbinectedin in Small Cell Lung Cancer

December 18th 2020

Dr Ticiana Leal, MD, discusses the role of topotecan and lurbinectedin as novel agents in second-line therapy for small cell lung cancer.

EP. 5: The Impact of Lurbinectedin in Small Cell Lung Cancer

December 18th 2020

Dr Ticiana Leal, MD, describes the choice to prescribe lurbinectedin in the second-line setting for the patient as well as her personal experience with the drug.

EP. 6: Evaluating Current Treatment Options for Small Cell Lung Cancer

December 18th 2020

Dr Ticiana Leal, MD, highlights the approvals of new regiments in small cell lung cancer. However, she discusses the struggles physicians currently face, such as identifying predictive biomarkers used to select patients who may respond well to new treatment regiments.